{
    "root": "2c3f6765-9d71-a7cf-e063-6394a90aaa49",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Amlodipine Besylate",
    "value": "20250121",
    "ingredients": [
        {
            "name": "ANHYDROUS DIBASIC CALCIUM PHOSPHATE",
            "code": "L11K75P92J",
            "chebi_id": null
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U",
            "chebi_id": null
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "chebi_id": null,
            "drugbank_id": "DB14077"
        },
        {
            "name": "POVIDONE",
            "code": "FZ989GH94E",
            "chebi_id": null,
            "drugbank_id": "DB11061"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": null,
            "drugbank_id": "DB11132"
        },
        {
            "name": "AMLODIPINE BESYLATE",
            "code": "864V2Q084H",
            "chebi_id": null,
            "drugbank_id": "DB00381"
        }
    ],
    "indications": [
        {
            "text": "amlodipine besylate tablets calcium channel blocker may used alone combination antihypertensive antianginal agents treatment : \u2022hypertension ( 1.1 ) \u043e amlodipine besylate tablets indicated treatment hypertension , lower blood pressure . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . \u2022coronary artery disease ( 1.2 ) \u043e chronic stable angina \u043e vasospastic angina ( prinzmetal 's variant angina ) \u043e angiographically documented coronary artery disease patients without heart failure ejection fraction < 40 %",
            "doid_id": null,
            "orphanet_entities": [
                {
                    "disease": "chronic stable angina",
                    "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_458775"
                }
            ]
        }
    ],
    "contraindications": [
        {
            "text": "\u2022adult recommended starting dose : 5 mg daily maximum dose 10 mg daily . ( 2.1 ) \u043e small , fragile , elderly patients , patients hepatic insufficiency may started 2.5 mg daily . ( 2.1 ) \u2022pediatric starting dose : 2.5 mg 5 mg daily . ( 2.2 ) important limitation : doses excess 5 mg daily studied pediatric patients . ( 2.2 )",
            "doid_id": null,
            "orphanet_entities": []
        }
    ],
    "warningsAndPrecautions": null,
    "adverseReactions": "known sensitivity amlodipine ( 4 )",
    "indications_original": "Amlodipine besylate tablets are calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of: \u2022Hypertension ( 1.1 ) \u043e\u00a0 Amlodipine besylate tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. \u2022Coronary Artery Disease ( 1.2 ) \u043e\u00a0Chronic Stable Angina \u043e\u00a0Vasospastic Angina (Prinzmetal's or Variant Angina) \u043e\u00a0Angiographically Documented Coronary Artery Disease in patients without heart failure or an ejection fraction < 40%",
    "contraindications_original": "\u2022Adult recommended starting dose: 5 mg once daily with maximum dose 10 mg once daily. ( 2.1 ) \u043e Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg once daily. ( 2.1 ) \u2022Pediatric starting dose: 2.5 mg to 5 mg once daily. ( 2.2 ) Important Limitation : Doses in excess of 5 mg daily have not been studied in pediatric patients. ( 2.2 )",
    "adverseReactions_original": "Known sensitivity to amlodipine ( 4 )",
    "drug": [
        {
            "name": "Amlodipine Besylate",
            "drugbank_id": "DB00381"
        }
    ]
}